Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Journal of Nanoscience and Nanotechnology
|
June 2, 2006
The role of gas dynamics in operation conditions of a Pulsed Microplasma Cluster Source for nanostructured thin films deposition
H Vahedi Tafreshi, P Piseri, G Benedek, et al.
Alimentary Pharmacology & Therapeutics
|
September 1, 2005
The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study
H Vahedi, S Merat, A Rashidioon, et al.
The Journal of Trauma
|
April 1, 1995
Pneumatic antishock garment-associated compartment syndrome in uninjured lower extremities
M H Vahedi, A Ayuyao, M H Parsa, et al.
Langmuir : the ACS Journal of Surfaces and Colloids
|
December 21, 2016
Novel Approach to Measuring the Droplet Detachment Force from Fibers
M M Amrei, D G Venkateshan, N D'Souza, et al.
Digestion
|
February 14, 2002
Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen
R Sotoudehmanesh, R Malekzadeh, H Vahedi, et al.
Alimentary Pharmacology & Therapeutics
|
July 19, 2003
Coeliac disease presenting with symptoms of irritable bowel syndrome
B Shahbazkhani, M Forootan, S Merat, et al.
European Journal of Gastroenterology & Hepatology
|
August 17, 2001
Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial
M J Kaviani, R Malekzadeh, H Vahedi, et al.
Alimentary Pharmacology & Therapeutics
|
February 6, 2008
Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome
H Vahedi, S Merat, S Momtahen, et al.
Scandinavian Journal of Immunology
|
November 30, 2016
Immunomodulatory and Immunosuppressive Roles of 1α,25(OH)2D3 in Autoimmune Diseases
H Alhassan Mohammed, A A Saboor-Yaraghi, A Mirshafiey, et al.
Scandinavian Journal of Immunology
|
March 24, 2017
Immunoregulation of Inflammatory and Inhibitory Cytokines by Vitamin D3 in Patients with Inflammatory Bowel Diseases
H Alhassan Mohammed, A Mirshafiey, H Vahedi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Journal of Nanoscience and Nanotechnology
|
June 2, 2006
The role of gas dynamics in operation conditions of a Pulsed Microplasma Cluster Source for nanostructured thin films deposition
H Vahedi Tafreshi, P Piseri, G Benedek, et al.
Alimentary Pharmacology & Therapeutics
|
September 1, 2005
The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study
H Vahedi, S Merat, A Rashidioon, et al.
The Journal of Trauma
|
April 1, 1995
Pneumatic antishock garment-associated compartment syndrome in uninjured lower extremities
M H Vahedi, A Ayuyao, M H Parsa, et al.
Langmuir : the ACS Journal of Surfaces and Colloids
|
December 21, 2016
Novel Approach to Measuring the Droplet Detachment Force from Fibers
M M Amrei, D G Venkateshan, N D'Souza, et al.
Digestion
|
February 14, 2002
Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen
R Sotoudehmanesh, R Malekzadeh, H Vahedi, et al.
Alimentary Pharmacology & Therapeutics
|
July 19, 2003
Coeliac disease presenting with symptoms of irritable bowel syndrome
B Shahbazkhani, M Forootan, S Merat, et al.
European Journal of Gastroenterology & Hepatology
|
August 17, 2001
Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial
M J Kaviani, R Malekzadeh, H Vahedi, et al.
Alimentary Pharmacology & Therapeutics
|
February 6, 2008
Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome
H Vahedi, S Merat, S Momtahen, et al.
Scandinavian Journal of Immunology
|
November 30, 2016
Immunomodulatory and Immunosuppressive Roles of 1α,25(OH)2D3 in Autoimmune Diseases
H Alhassan Mohammed, A A Saboor-Yaraghi, A Mirshafiey, et al.
Scandinavian Journal of Immunology
|
March 24, 2017
Immunoregulation of Inflammatory and Inhibitory Cytokines by Vitamin D3 in Patients with Inflammatory Bowel Diseases
H Alhassan Mohammed, A Mirshafiey, H Vahedi, et al.
Page
of 3